Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ May 27, 2023 ] Administrative Assistant, Technology Center for Genomics & Bioinformatics – UCLA Health – Los Angeles, CA Los Angeles Biotech Jobs
  • [ May 27, 2023 ] Staff Research Associate I – Biological Chemistry – UCLA Health – Los Angeles, CA Los Angeles Biotech Jobs
  • [ May 27, 2023 ] QC Instrumentation Engineer – PSC Biotech – Pomona, CA Los Angeles Biotech Jobs
  • [ May 27, 2023 ] Project Engineer – PSC Biotech – Pomona, CA Los Angeles Biotech Jobs
  • [ May 27, 2023 ] Technologist, Microbiology Laboratory – Edwards Lifesciences – Irvine, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsSTAT+: Liver disease researchers are hoping AI can improve their trial design

STAT+: Liver disease researchers are hoping AI can improve their trial design

April 7, 2023 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on STAT+: Liver disease researchers are hoping AI can improve their trial design
Researchers hope that tools like ChatGPT could be useful in helping find targets in the “multi-modal conspiracy” that leads to NASH and other diseases of the liver.

Click to view original post

Previous

Postdoctoral Researcher, Plant Sciences – Cal Poly Corporation – San Luis Obispo, CA

Next

Postdoctoral Scholar – Research Associate – USC – Los Angeles, CA

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered